2 active not recruiting, 1 recruiting. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Technetium Tc-99m Sestamibi: new trials by email Literature Review of Technetium Tc-99m Sestamibi trials Research Report on Technetium Tc-99m Sestamibi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities Biopsy of Breast, Medical Device Usage and Evaluation, Scintimammography - Breast Neoplasm | Not applicable | Recruiting | Mayo Clinic | 70 | 2021-08-26 | 2026-10-05 |
| SPECT/CT for the Characterization of Renal Masses Computed Tomography, Questionnaire Administration, Single Photon Emission Computed Tomography - Kidney Neoplasm, Renal Mass | Active not recruiting | Jonsson Comprehensive Cancer Center | 102 | 2018-12-07 | 2026-03-13 | |
| DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Laboratory Biomarker Analysis, Scintimammography - Estrogen Receptor Negative, HER2/Neu Negative | Early Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 96 | 2016-11-07 | 2026-10-07 |
Breast Neoplasms (1) · Kidney Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1)
United States (3)
Brian Shuch (1) · Gaiane M Rauch (1) · Katie N. Hunt, M.D. (1)
P30CA016672 (1)